Breaking News

WuXi NextCODE Invests $400M to Expand Precision Medicine Efforts in Ireland

Includes the acquisition of Genomics Medicine Ireland

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi NextCODE, a life sciences informatics company, has unveiled its plan to create in Ireland a dataset for genome-driven drug discovery and create a model for delivering the benefits of precision medicine. Leading the effort will be its long-time partner, Genomics Medicine Ireland (GMI), which has become the company’s Irish subsidiary and hub of its European business. The GMI acquisition forms part of a $400 million investment program in precision medicine unveiled in Dublin.   GMI aim...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters